Evidence map›Paper›PMID 36988664›Full record

ArticleArchives of dermatological research2023

Surgical resection margin for T3-T4 primary acral melanoma: a multicenter retrospective cohort study.

Wei Sun, Yu Xu, XingLong Qu, YongJia Jin, ChunMeng Wang, WangJun Yan, Yong Chen

Abstract readMulticenter Study
In one paragraph

Article in Archives of dermatological research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Current Surgical Management for Acral Melanoma.Current treatment options in oncology · 2025
    Review
  3. Article
  4. Current surgical management for melanoma.The Journal of dermatology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wei SunDepartment of Musculoskeletal Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, People's Republic of China.
Yu XuDepartment of Musculoskeletal Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, People's Republic of China.
XingLong QuDepartment of Oncological Surgery, Minhang Branch, Shanghai Cancer Center, Fudan University, Shanghai, 200240, People's Republic of China.
YongJia JinShanghai Electric Power Hospital, Shanghai, 200050, People's Republic of China.
ChunMeng WangDepartment of Musculoskeletal Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, People's Republic of China.
WangJun YanDepartment of Musculoskeletal Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, People's Republic of China. yanwj@fudan.edu.cn.
Yong ChenDepartment of Musculoskeletal Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, People's Republic of China. chenyong@fudan.edu.cn.

Funding

National Natural Science Foundation of China 82272857the Lingang Laboratory LG-QS-202205-11the Shanghai Committee of Science and Technology 19411951700
6 · The paper itself

Abstract

Although the National Comprehensive Cancer Network (NCCN) guidelines include clear recommendations for the appropriate resection margins in non-acral cutaneous melanoma, the required margin for acral melanoma is controversial. In this retrospective study, we aimed to investigate whether narrow-margin excision is warranted for thick acral melanoma. Records from 277 melanoma patients with stage T3-T4 disease who underwent radical surgery in three centers in China from September 2010 to October 2018 were reviewed. Clinicopathologic data, including age, gender, excision margin (1-2 cm versus ≥ 2 cm), Clark level, Breslow thickness, ulceration, N stage and adjuvant therapy, were included for survival analysis. The patients were followed up until death or March 31, 2021. Log-rank and Cox regression analyses were used to identify prognostic factors for overall survival (OS), disease-free survival (DFS) and local and in-transit recurrence-free survival (LITRFS). Among all enrolled patients, 207 (74.7%) had acral melanoma, and 70 (25.3%) had non-acral cutaneous melanoma. No significant difference in baseline characteristics was identified between non-acral and acral melanoma, except for age (p = 0.004), gender (p = 0.009) and ulceration (p = 0.048). In non-acral melanoma, a resection margin of 1-2 cm was a poor independent prognostic factor for OS [p = 0.015; hazard ratio (HR) (95% CI), 0.26 (0.009-0.77)] and LITRFS [p = 0.013; HR (95% CI), 0.19 (0.05-0.71)] but not for DFS [p = 0.143; HR (95% CI), 0.51 (0.21-1.25)]. Forty-three (20.8%) patients in the acral melanoma group had a 1-2-cm resection margin. The resection margin was not correlated with patients' OS (p = 0.196 by log-rank analysis, p = 0.865 by multivariate survival analysis), DFS (p = 0.080 by log-rank analysis, p = 0.758 by multivariate survival analysis) or LITRFS (p = 0.354 by log-rank analysis) in acral melanoma. As recommended in the NCCN guidelines, a resection margin ≥ 2 cm is required for non-acral cutaneous melanoma. Meanwhile, a narrow resection margin (1-2 cm) may be safe for patients with acral melanoma.

Indexed as

MelanomaSkin NeoplasmsCutaneous Malignant MelanomaHumansMargins of ExcisionNeoplasm Recurrence, LocalPrognosisRetrospective StudiesAcral melanomaBreslow indexCutaneous melanomaResection marginSurvival

Identifiers

PMID36988664
PMCPMC10462526

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.